Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 March 2018 Photo Edwin Mthimkhulu
Solomon Mahlangu inspires UFS alumnus first Sesotho book
Ace Moloi questions and delves into the concept of freedomin Tholwana Tsa Tokoloho

Tholwana Tsa Tokoloho is the title of Ace Moloi’s anthology of short stories and the name of one of the 14 stories in the book. The anthology is the first book in Sesotho published by the three-time author.

On Friday, 16 March 2018, Tholwana Tsa Tokoloho, an Art Fusion Literature product, will make its debut public appearance during a public reading at the University of the Free State’s Equitas Auditorium at 17:30.

Moloi’s first literary offering was In Her Fall Rose A Nation which was published in 2013 during his final-year as a Communication Science student at the university. In 2016, Moloi published Holding My Breath, which was praised widely for stirring emotions in readers who related to the heart-wrenching narrative of losing a mother. It was only this year that the author managed to achieve his teenage goal of establishing himself as a vernacular author.

Solomon Mahlangu, an African National Congress freedom fighter and Umkhonto we Sizwe militant who was convicted of murder and hanged in 1979, was the inspiration behind the anthology. Mahlangu inspired the Tholwana Tsa Tokoloho story, which is the story of the selflessness of a captured guerrilla hero in the face of police torture and his eventual death by hanging. It represents Mahlangu and those who suffered during the struggle for liberation. 

“My blood will nourish the tree that will bear the fruits of freedom,” are the supposed last words uttered by Mahlangu that inspired the book’s title. Tholwana Tsa Tokoloho means “the fruits of freedom” in Sesotho. For Moloi, writing in the vernacular symbolises the fruits of freedom. “I’m trying to write in a revolutionary spirit, in Sesotho, because we haven’t done that. We have not seriously interrogated political concepts in Sesotho or in any native language,” he said.

Graduate unemployment, violent crime, and sports are some of the other topics tackled in the book. These act as a catalyst for debates over the evidence of ‘the fruits of freedom’ in post-1994 South Africa. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept